Strength
750 mg/1
Manufacturer
AvPAKNDC
50268052115
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHOCARBAMOLApproval Type
Generic (ANDA)
FDA Application
ANDA090200On Market Since
3/23/2021
Pharmacological Classes
Price Statistics
The NADAC for METHOCARBAMOL 750 MG TABLET has been published 259 times since Jul 14, 2021, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0429 per EA |
|---|---|
| All-time high | $0.0931 (Apr 13, 2022) |
| All-time low | $0.0346 (Jul 17, 2024) |
| 52-week high | $0.0445 |
| 52-week low | $0.0423 |
| Median price | $0.0474 |
| Average price | $0.0532 |
| Largest weekly change | +34.4% (Aug 21, 2024) |
| Weeks tracked | 259 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHOCARBAMOL 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHOCARBAMOL 750 MG TABLET, manufactured by AvPAK, is $0.0429 per EA (NDC 50268052115), effective Jun 24, 2026.
How has the price of METHOCARBAMOL 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHOCARBAMOL 750 MG TABLET has declined 50.5%. It has been tracked across 259 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for METHOCARBAMOL 750 MG TABLET?
Since Jul 14, 2021, the NADAC for METHOCARBAMOL 750 MG TABLET has ranged from a low of $0.0346 (Jul 17, 2024) to a high of $0.0931 (Apr 13, 2022), with a median of $0.0474 per EA.
Are there cheaper alternatives to METHOCARBAMOL 750 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as METHOCARBAMOL 750 MG TABLET, but none are currently priced below it.
Who manufactures METHOCARBAMOL 750 MG TABLET?
METHOCARBAMOL 750 MG TABLET (NDC 50268052115) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification